Michael Makanga

Efficacy and safety of artemether–lumefantrine (Coartem®) tablets (six-dose regimen) in African infants and children with acute, uncomplicated falciparum malaria

Catherine O. Falade, Michael Makanga, Zul Premji et al. · Transactions of the Royal Society of Tropical Medicine and Hygiene · 2005 · 160 citations

African Infants, Translational Medicine, Uncomplicated Falciparum Malaria +11

EFFICACY AND SAFETY OF THE SIX-DOSE REGIMEN OF ARTEMETHER-LUMEFANTRINE IN PEDIATRICS WITH UNCOMPLICATED PLASMODIUM FALCIPARUM MALARIA: A POOLED ANALYSIS OF INDIVIDUAL PATIENT DATA

Michael Makanga, Zul Premji, Catherine O. Falade et al. · American Journal of Tropical Medicine and Hygiene · 2006 · 82 citations

Patient Data, Health Sciences, Clinical Therapeutic +11

Scientific impact increases when researchers publish in open access and international collaboration: A bibliometric analysis on poverty-related disease papers

J. Gabrielle Breugelmans, Guillaume Roberge, Chantale Tippett et al. · PLoS ONE · 2018 · 79 citations · Full text

Community screening and treatment of asymptomatic carriers of Plasmodium falciparum with artemether-lumefantrine to reduce malaria disease burden: a modelling and simulation analysis

Steven E. Kern, Alfred B. Tiono, Michael Makanga et al. · Malaria Journal · 2011 · 74 citations · Full text

Treatment of asymptomatic carriers with artemether-lumefantrine: an opportunity to reduce the burden of malaria?

Bernhards Ogutu, Alfred B. Tiono, Michael Makanga et al. · Malaria Journal · 2010 · 59 citations · Full text